SS
CRVO icon

SBI Securities’s CervoMed CRVO Stock Holding History

SBI Securities’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791 Buy
255
+117
+85% +$412 ﹤0.01% 2884
2026
Q1 		$544 Sell
138
-88
-39% -$460 ﹤0.01% 2863
2025
Q4 		$1.78K Sell
226
-11
-5% -$88 ﹤0.01% 2433
2025
Q3 		$1.92K Sell
237
-40
-14% -$343 ﹤0.01% 2439
2025
Q2 		$1.74K Buy
277
+63
+29% +$537 ﹤0.01% 2449
2025
Q1 		$1.96K Buy
214
+59
+38% +$225 ﹤0.01% 2300
2024
Q4 		$363 Buy
+155
New +$1.51K ﹤0.01% 3011

Other funds holding CRVO

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

SBI Securities's CRVO Position: Q2 2026 in Review

SBI Securities increased its CervoMed (CRVO) stake by 85% in Q2 2026, buying an estimated $412 and bringing the position to 255 shares worth $791. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

SBI Securities first reported a position in CRVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.96K in Q1 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • SBI Securities held 255 shares of CervoMed worth $791 as of Q2 2026.
  • SBI Securities bought 117 CervoMed shares in Q2 2026, an estimated $412.
  • CervoMed made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2884 holding.
  • SBI Securities first reported a position in CervoMed in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's CervoMed position peaked at $1.96K in Q1 2025.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.